InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Explore the full record of transactions filed by Bonello William, Chairman & CEO. Director active across 1 companies, notably Neogenomics INC. In total, 10 reports have been published. Total volume traded: €54k. The latest transaction was disclosed on 28 April 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations10 total
€41,0005,727 shares@ €7.1590.0038% mcap5.2% of flow
Common Stock
SEC:0001077183-22-000071:0·
082,305 shares0
Common Stock
SEC:0001077183-22-000056:0·
€53,9733,209 shares@ €16.81910.0050% mcap6.9% of flow
Common Stock
SEC:0001077183-22-000049:0·
040,869 shares0
Common Stock
SEC:0001077183-22-000040:0·
021,400 shares0
Common Stock
SEC:0001077183-21-000275·
021,400 shares0
Common Stock
SEC:0001077183-21-000275:0·
€166,46825,000 shares@ €6.65870.016% mcap48.3% of flow
Common Stock
SEC:0001077183-21-000254·
€166,46825,000 shares@ €6.65870.016% mcap21.2% of flow
Common Stock
SEC:0001077183-21-000254:0·
€178,52525,000 shares@ €7.1410.017% mcap51.7% of flow
Common Stock
SEC:0001077183-21-000251·
€178,52525,000 shares@ €7.1410.017% mcap22.7% of flow
Common Stock
SEC:0001077183-21-000251:0·
10 of 10 declarations
About Bonello William
William Bonello is the President, Informatics, and Chief Financial Officer at Neogenomics Inc. He oversees the financial operations and IT strategies of the company. Neogenomics specializes in genetic diagnostic services. William's experience in both finance and technology is essential for the company's innovation and growth.
